Submitted for Publication: January 29, 2014; final revision received June 12, 2014; accepted July 21, 2014.
Corresponding Author: Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Ste 215, Boston, MA 02115-5899 (kessler@hcp.med.harvard.edu).
Published Online: November 12, 2014. doi:10.1001/jamapsychiatry.2014.1754.
Author Contributions: Dr Kessler had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Kessler, Cai, Colpe, Fullerton, Gilman, Heeringa, Naifeh, Rosellini, Schoenbaum, Wessely, Ursano.
Acquisition, analysis, or interpretation of data: Kessler, Warner, Ivany, Petukhova, Rose, Bromet, Brown, Cox, Gruber, Heeringa, Lewandowski-Romps, Li, Millikan-Bell, Nock, Rosellini, Sampson, Schoenbaum, Stein, Zaslavsky, Ursano.
Drafting of the manuscript: Kessler, Rosellini, Schoenbaum, Ursano.
Critical revision of the manuscript for important intellectual content: Kessler, Warner, Ivany, Petukhova, Rose, Bromet, Brown, Cai, Colpe, Cox, Fullerton, Gilman, Gruber, Heeringa, Lewandowski-Romps, Li, Millikan-Bell, Naifeh, Nock, Rosellini, Sampson, Stein, Wessely, Zaslavsky, Ursano.
Statistical analysis: Kessler, Ivany, Petukhova, Rose, Cai, Gruber, Heeringa, Li, Rosellini, Sampson, Schoenbaum, Zaslavsky.
Obtained funding: Kessler, Ursano.
Administrative, technical, or material support: Kessler, Brown, Colpe, Fullerton, Heeringa, Lewandowski-Romps, Millikan-Bell, Naifeh, Nock, Rosellini, Ursano.
Study supervision: Kessler, Bromet, Sampson, Schoenbaum, Stein, Wessely, Ursano.
Conflict of Interest Disclosures: Dr Kessler reported being a consultant for AstraZeneca, Analysis Group, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, GlaxoSmithKline Inc, HealthCore Inc, Health Dialog, Hoffman-LaRoche Inc, Integrated Benefits Institute, J & J Wellness & Prevention Inc, John Snow Inc, Kaiser Permanente, Lake Nona Institute, Matria Inc, Mensante, Merck & Co Inc, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Primary Care Network, Research Triangle Institute, Sanofi-Aventis Groupe SA, Shire US Inc, SRA International Inc, Takeda Global Research & Development, Transcept Pharmaceuticals Inc, and Wyeth-Ayerst. Dr Kessler reported serving on advisory boards for Appliance Computing II, Eli Lilly & Company, Mindsite, Ortho-McNeil Janssen Scientific Affairs, Johnson & Johnson, Plus One Health Management, and Wyeth-Ayerst and receiving research support for his epidemiologic studies from Analysis Group Inc, Bristol-Myers Squibb, Eli Lilly & Company, EPI-Q, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Sanofi-Aventis Groupe SA, Shire US Inc, and Walgreens Co. Dr Kessler reported owing a 25% share in DataStat Inc. Dr Stein reported being a consultant for Healthcare Management Technologies and receiving research support for pharmacologic imaging studies from Janssen. No other disclosures were reported.
Funding/Support: The Army STARRS was sponsored by the US Department of the Army and funded under cooperative agreement U01MH087981 with the National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services.
Role of the Funder/Sponsor: As a cooperative agreement, scientists employed by the National Institute of Mental Health (Drs Colpe and Schoenbaum) and US Army liaisons and consultants (Dr Cox and Steven Cersovsky, MD, MPH) collaborated to develop the study protocol and data collection instruments, supervise data collection, interpret results, and prepare reports. Although a draft of the manuscript was submitted to the US Army and the National Institute of Mental Health for review and comment before submission, this was with the understanding that comments would be only advisory.
Group Information: The Army STARRS coprincipal investigators were Robert J. Ursano, MD (Uniformed Services University of the Health Sciences), and Murray B. Stein, MD, MPH (University of California, San Diego, and Veterans Affairs San Diego Healthcare System). The site principal investigators were Steven G. Heeringa, PhD (University of Michigan), and Ronald C. Kessler, PhD (Harvard Medical School). The National Institute of Mental Health collaborating scientists were Lisa J. Colpe, PhD, MPH, and Michael Schoenbaum, PhD. The US Army liaisons and consultants were Steven Cersovsky, MD, MPH, and Kenneth L. Cox, MD, MPH.
Other team members were Pablo A. Aliaga, MA (Uniformed Services University of the Health Sciences), David M. Benedek, MD (Uniformed Services University of the Health Sciences), Susan Borja, PhD (National Institute of Mental Health), Gregory G. Brown, PhD (University of California, San Diego), Laura Campbell-Sills, PhD (University of California, San Diego), Catherine L. Dempsey, PhD, MPH (Uniformed Services University of the Health Sciences), Richard Frank, PhD (Harvard Medical School), Carol S. Fullerton, PhD (Uniformed Services University of the Health Sciences), Nancy Gebler, MA (University of Michigan), Robert K. Gifford, PhD (Uniformed Services University of the Health Sciences), Stephen E. Gilman, ScD (Harvard School of Public Health), Marjan G. Holloway, PhD (Uniformed Services University of the Health Sciences), Paul E. Hurwitz, MPH (Uniformed Services University of the Health Sciences), Sonia Jain, PhD (University of California, San Diego), Tzu-Cheg Kao, PhD (Uniformed Services University of the Health Sciences), Karestan C. Koenen, PhD (Columbia University), Lisa Lewandowski-Romps, PhD (University of Michigan), Holly Herberman Mash, PhD (Uniformed Services University of the Health Sciences), James E. McCarroll, PhD, MPH (Uniformed Services University of the Health Sciences), Katie A. McLaughlin, PhD (Harvard Medical School), James A. Naifeh, PhD (Uniformed Services University of the Health Sciences), Matthew K. Nock, PhD (Harvard University), Rema Raman, PhD (University of California, San Diego), Sherri Rose, PhD (Harvard Medical School), Anthony Joseph Rosellini, PhD (Harvard Medical School), Nancy A. Sampson, BA (Harvard Medical School), LCDR Patcho Santiago, MD, MPH (Uniformed Services University of the Health Sciences), Michaelle Scanlon, MBA (National Institute of Mental Health), Jordan Smoller, MD, ScD (Harvard Medical School), Michael L. Thomas, PhD (University of California, San Diego), Patti L. Vegella, MS, MA (Uniformed Services University of the Health Sciences), Christina Wassel, PhD (University of Pittsburgh), and Alan M. Zaslavsky, PhD (Harvard Medical School).
Disclaimer: The contents are solely the responsibility of the authors and do not necessarily represent the views of the US Department of Health and Human Services, the National Institute of Mental Health, the US Department of the Army, or the US Department of Defense.
Additional Contributions: John Mann, MD, Maria Oquendo, MD, Barbara Stanley, PhD, Kelly Posner, PhD, and John Keilp, PhD, Department of Psychiatry, Columbia University, College of Physicians and Surgeons, and New York State Psychiatric Institute, New York, contributed to the early stages of the US Army STARRS development.